Cremer S, Pilgram L, Berkowitsch A, Stecher M, et al. Angiotensin II receptor blocker intake associates with reduced markers of
inflammatory activation and decreased mortality in patients with cardiovascular
comorbidities and COVID-19 disease. PLoS One 2021;16:e0258684.
PMID: 34673795